The following list of published research is intended to serve as a resource for study of inflammatory myopathies.
2017
- Spencer CH, et. al. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. Pediatric Rheumatology (2017), 15:50. DOI 10.1186/s12969-017-0174-0.
- T Kishi, LG Rider, K Pak, L Barillas-Arias, M Henrickson, PL McCarthy, B Shaham, PF Weiss, I Horkayne-Szakaly, IN Targoff, FW MILLER, AL Mammen, for the Childhood Myositis Heterogeneity Study Group. Association of anti–3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care & Research. 2017, 69(7):1088–1094. DOI 10.1002/acr.23113.
- Claire Deakin, John Bowes, Lucy Marshall, Cerise Johnson, Gulnara Mamyrova, Rodolfo Curiel, Kelly A. Rouster-Stevens, Heinrike Schmeling, Adam Huber, Brian M. Feldman, Ann M Reed, Lauren M. Pachman, Soumya Raychaudhuri, Stephen Eyre, Lucy R Wedderburn. The interaction between genetic risk factors and age of disease onset in juvenile dermatomyositis. ACR/ARHP Annual Meeting, November 7, 2017. [TMA-funded research]
2016
- L. G. Rider and K. Nistala. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. Journal of Internal Medicine. DOI: 10.1111/joim.12444.
- Deakin, C. T., Yasin, S. A., Simou, S., Arnold, K. A., Tansley, S. L., Betteridge, Z. E., McHugh, N. J., Varsani, H., Holton, J. L., Jacques, T. S., Pilkington, C. A., Nistala, K., Wedderburn, L. R., and on behalf of the UK Juvenile Dermatomyositis Research Group. Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis. Arthritis & Rheumatology. 2016 Oct; 68: 2806–2816. doi:10.1002/art.39753.
- R Campanilho-Marques, B Almeida, C Deakin, K Arnold, N Gallot, M De Iorio, K Nistala, CA Pilkington, LR Wedderburn on behalf of the Juvenile Dermatomyositis Research Group. Comparison of the utility and validity of three scoring tools to measure skin involvement in patients with juvenile dermatomyositis. Arthritis Care & Research. 2016, 68(10): 1514–1521. DOI 10.1002/acr.22867
- Takayuki Kishi, Nastaran Bayat, Michael Ward, Adam Huber, Lan Wu, Gulnara Mamyrova, Ira Targo, William Warren-Hicks, Frederick W. Miller, Lisa G. Rider, the Childhood Myositis Heterogeneity Study Group. Trends in medication usage in patients with juvenile dermatomyositis. ACR/ARHP Annual Meeting, November 14, 2016. [TMA-funded research]
2015
- Hemlata Varsani, Susan C Charman, Charles K Li, Suely K N Marie, Anthony A Amato, Brenda Banwell, Kevin E Bove, Andrea M Corse, Alison M Emslie-Smith, Thomas S Jacques, Ingrid E Lundberg, Carlo Minetti, Inger Nennesmo, Elisabeth J Rushing, Adriana M E Sallum, Caroline Sewry, Clarissa A Pilkington, Janice L Holton, Lucy R Wedderburn, the UK Juvenile Dermatomyositis Research Group. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Varsani H, et al. Ann Rheum Dis 2015; 74 :204-210. doi:10.1136/annrheumdis-2013-203396
- Nicolino Ruperto, Angela Pistorio, Sheila Oliveira, Francesco Zulian, Ruben Cuttica, Angelo Ravelli, Michel Fischbach, Bo Magnusson, Gary Sterba, Tadej Avcin, Karine Brochard, Fabrizia Corona, Frank Dressler, Valeria Gerloni, Maria T Apaz, Claudia Bracaglia, Adriana Cespedes-Cruz, Rolando Cimaz, Gerard Couillault, Rik Joos, Pierre Quartier, Ricardo Russo, Marc Tardieu, Nico Wulff raat, Blanca Bica, Pavla Dolezalova, Virginia Ferriani, Berit Flato, Ana G Bernard-Medina, Troels Herlin, Maria Trachana, Antonella Meini, Emma Allain-Launay, Clarissa Pilkington, Veronika Vargova, Carine Wouters, Simona Angioloni, Alberto Martini, for the Paediatric Rheumatology International Trials Organisation. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. www.thelancet.com Published online November 29, 2015 http://dx.doi.org/10.1016/S0140-6736(15)01021-1.
- CM Artlett, S Sassi-Gaha, RC Ramos, FW Miller, LG Rider. Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy. Arthritis Research & Therapy. 2015, 17:238. DOI 10.1186/s13075-015-0732-0
2010
- Angelo Ravelli, Lucia Trail, Cristina Ferrari, et. al. Long-Term Outcome and Prognostic Factors of Juvenile Dermatomyositis: A Multinational, Multicenter Study of 490 Patients Arthritis Care & Research 2010; 62:63-72.
2009
- Lucy R. Wedderburn, Lisa G. Rider. Juvenile dermatomyositis: new developments inpathogenesis, assessment and treatment. Best Practice & Research Clinical Rheumatology. 23 (2009) 665-678.
- Rider, Lachenbruch, Monroe, Ravelli, Cabalar, Feldman, Villalba, Myones, Pachman, Rennebohm, Reed and Miller for the IMACS Groups. Damage Extent and Predictors in Adult Juvenile Dermatomyositis and Polymyositis as determined with the myositis damage index. Arthritis & Rheumatism; vol. 60, No. 11, November 2009, pp 3425-3435. DOI 10.1002/art.24904.
- Adam M. Huber. IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada. IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada. Pediatr Drugs 2009; 11 (6); 361-374 “The pdf of the paper in this link has been provided with permission of Adis, a Wolters Kluwer business, for personal research purposes only. © Adis Data Information BV 2009.”
2006 – 2007
- Stringer E, Feldman BM. Advances in the treatment of juvenile dermatomyositis. Current Opinion in Rheumatology. 2006;18:503-6.
- Brown VE, Pilkington CA, Feldman BM, Davidson JE. Juvenile Dermatomyositis Research Centre, Institute of Child Health, University College London, UK. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford). 2006 Feb 8 [Epub ahead of print]
- Chiu SK, Yang YH, Wang LC, Chiang BL. Ten-year experience of juvenile dermatomyositis: a retrospective study. Journal of Microbiology, Immunology and Infection. 2007;40:68-73.
2001 – 2005
- Tomono N, Mori M, Nakajima S, Miyamae T, Ito S, Mitsuda T, Yokota S. HLA-DRB1*15021 Is the Predominant Allele in Japanese Patients with Juvenile Dermatomyositis. Journal of Rheumatology 2004 September; 31(9):1847-50.
- Sarkar K and Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmune Review 2004 August; 3(6):454-63.
- Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. Journal of Rheumatology 2004 August; 31(8):1644-9.
- Maillard SM, Jones R, Owens C, Pilkington C, Woo P, Wedderburn LR, Murray KJ. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004 May; 43(5):603-8.
- Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer J, Pachman LM. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases registry. Arthritis and Rheumatism 15 June 2003; 49 (3): 300-305.